| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 57 | 313 | 106 | | Cost of Revenue | 11 | 66 | 73 | | | Gross Profit | 46 | 247 | 33 | | | Operating Expenses | | Research Development | 6,167 | 11,314 | 6,878 | | Selling General and Administrative | 5,547 | 3,436 | 6,372 | | Non Recurring |
-
|
-
|
-
| | Others | 182 | 184 | 91 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (11,850) | (14,687) | (13,308) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46 | 328 | 128 | | Earnings Before Interest And Taxes | (11,804) | (14,359) | (13,180) | | Interest Expense | 2,401 | 3,708 | 1 | | Income Before Tax | (14,205) | (18,067) | (13,181) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,205) | (18,067) | (13,181) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,205) | (18,067) | (13,181) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,205) | ($18,067) | ($13,181) |
|
0.11% Nasdaq 
0.01%
Income Statement
